Short-term, low-dose etoposide in refractory adult-onset Still's disease-associated macrophage activation syndrome.

导出原文传递

翻译打印收藏纠错

第一作者： Ran,Wang

第一单位： Department of Rheumatology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200001, China.

作者： Ran,Wang ^[1] ; Ting,Li ^[1] ; Shuang,Ye ^[1] ; Liangjin,Lv ^[1] ; Sheng,Chen ^[1] ; Xiaodong,Wang ^[1] ; Chun-de,Bao ^[2] ; Qiong,Fu ^[3]

作者单位： Department of Rheumatology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200001, China. ^[1] Department of Rheumatology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200001, China. baochunde_1678@126.com. ^[2] Department of Rheumatology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai, 200001, China. fuqiong@renji.com. ^[3]

关键词 Adult-onset Still’s disease Etoposide Macrophage activation syndrome

主题词成年人(Adult);依托泊甙(Etoposide);人类(Humans);淋巴组织细胞增多症, 嗜血细胞性(Lymphohistiocytosis, Hemophagocytic);巨噬细胞活化综合征(Macrophage Activation Syndrome);预后(Prognosis);Still病, 成年型(Still's Disease, Adult-Onset)

DOI 10.1007/s10067-022-06184-1

PMID 35590113

发布时间 2022-09-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交